CN1400016A - Capsule for cleaning blood and reducing fat - Google Patents
Capsule for cleaning blood and reducing fat Download PDFInfo
- Publication number
- CN1400016A CN1400016A CN 02135419 CN02135419A CN1400016A CN 1400016 A CN1400016 A CN 1400016A CN 02135419 CN02135419 CN 02135419 CN 02135419 A CN02135419 A CN 02135419A CN 1400016 A CN1400016 A CN 1400016A
- Authority
- CN
- China
- Prior art keywords
- parts
- grams
- capsule
- radix
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004369 blood Anatomy 0.000 title claims abstract description 46
- 239000008280 blood Substances 0.000 title claims abstract description 46
- 239000002775 capsule Substances 0.000 title claims abstract description 28
- 238000004140 cleaning Methods 0.000 title claims description 24
- 239000003814 drug Substances 0.000 claims abstract description 30
- 241000190633 Cordyceps Species 0.000 claims abstract description 12
- 241000222336 Ganoderma Species 0.000 claims abstract description 12
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 12
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 12
- 235000008434 ginseng Nutrition 0.000 claims abstract description 12
- 238000001035 drying Methods 0.000 claims abstract description 9
- 238000010298 pulverizing process Methods 0.000 claims abstract description 9
- 241000208340 Araliaceae Species 0.000 claims description 11
- 241000180649 Panax notoginseng Species 0.000 claims description 11
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 11
- 241000195474 Sargassum Species 0.000 claims description 11
- 241000221377 Auricularia Species 0.000 claims description 10
- 241001489978 Eupolyphaga Species 0.000 claims description 10
- 241000628997 Flos Species 0.000 claims description 5
- 210000000582 semen Anatomy 0.000 claims description 5
- 241000233948 Typha Species 0.000 claims description 4
- JEIPFZHSYJVQDO-UHFFFAOYSA-N ferric oxide Chemical compound O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 claims description 2
- 238000011282 treatment Methods 0.000 abstract description 8
- 150000002632 lipids Chemical class 0.000 abstract description 2
- 241000748223 Alisma Species 0.000 abstract 1
- 244000028550 Auricularia auricula Species 0.000 abstract 1
- 235000000023 Auricularia auricula Nutrition 0.000 abstract 1
- 235000014493 Crataegus Nutrition 0.000 abstract 1
- 241001092040 Crataegus Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 238000000605 extraction Methods 0.000 abstract 1
- 239000009427 jiangzhi Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 208000031226 Hyperlipidaemia Diseases 0.000 description 5
- 230000002265 prevention Effects 0.000 description 5
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 3
- 230000003419 expectorant effect Effects 0.000 description 3
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 208000004930 Fatty Liver Diseases 0.000 description 2
- 206010019708 Hepatic steatosis Diseases 0.000 description 2
- RYMZZMVNJRMUDD-UHFFFAOYSA-N SJ000286063 Natural products C12C(OC(=O)C(C)(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 RYMZZMVNJRMUDD-UHFFFAOYSA-N 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000003143 atherosclerotic effect Effects 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 208000010706 fatty liver disease Diseases 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 235000015170 shellfish Nutrition 0.000 description 2
- 229960002855 simvastatin Drugs 0.000 description 2
- RYMZZMVNJRMUDD-HGQWONQESA-N simvastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)C(C)(C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 RYMZZMVNJRMUDD-HGQWONQESA-N 0.000 description 2
- 231100000240 steatosis hepatitis Toxicity 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical group CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 241000131329 Carabidae Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 208000031288 Combined hyperlipidaemia Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- HEMJJKBWTPKOJG-UHFFFAOYSA-N Gemfibrozil Chemical compound CC1=CC=C(C)C(OCCCC(C)(C)C(O)=O)=C1 HEMJJKBWTPKOJG-UHFFFAOYSA-N 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 244000153234 Hibiscus abelmoschus Species 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 208000000501 Lipidoses Diseases 0.000 description 1
- 206010024585 Lipidosis Diseases 0.000 description 1
- PCZOHLXUXFIOCF-UHFFFAOYSA-N Monacolin X Natural products C12C(OC(=O)C(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 PCZOHLXUXFIOCF-UHFFFAOYSA-N 0.000 description 1
- TUZYXOIXSAXUGO-UHFFFAOYSA-N Pravastatin Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(O)C=C21 TUZYXOIXSAXUGO-UHFFFAOYSA-N 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 206010047571 Visual impairment Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 238000011284 combination treatment Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 229960002297 fenofibrate Drugs 0.000 description 1
- YMTINGFKWWXKFG-UHFFFAOYSA-N fenofibrate Chemical compound C1=CC(OC(C)(C)C(=O)OC(C)C)=CC=C1C(=O)C1=CC=C(Cl)C=C1 YMTINGFKWWXKFG-UHFFFAOYSA-N 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 229960003627 gemfibrozil Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 108010022197 lipoprotein cholesterol Proteins 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229960004844 lovastatin Drugs 0.000 description 1
- PCZOHLXUXFIOCF-BXMDZJJMSA-N lovastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 PCZOHLXUXFIOCF-BXMDZJJMSA-N 0.000 description 1
- QLJODMDSTUBWDW-UHFFFAOYSA-N lovastatin hydroxy acid Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(C)C=C21 QLJODMDSTUBWDW-UHFFFAOYSA-N 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229960002965 pravastatin Drugs 0.000 description 1
- TUZYXOIXSAXUGO-PZAWKZKUSA-N pravastatin Chemical compound C1=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@H]2[C@@H](OC(=O)[C@@H](C)CC)C[C@H](O)C=C21 TUZYXOIXSAXUGO-PZAWKZKUSA-N 0.000 description 1
- 239000008911 qingzhi Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 208000029257 vision disease Diseases 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention provides a Chinese medicine for reducing blood lipid-Qingxue Jiangzhi capsule. It is made of 16 Chinese medicinal materials of ginseng, ganoderma, cordyceps, alisma tuber, rhubarb, Jew's-ear, crataegus fruit and others through the processes of drying, pulverizing, extraction effective components, concentrating and capsulizing to obtain the invented finished product. It can quickly obtain result, can obviously reduce blood lipid, does not damage human body and is short in course of treatment.
Description
Affiliated technical field
The present invention relates to a kind of medicine, be specifically related to a kind of Chinese medicine, more specifically to a kind of capsule for cleaning blood and reducing fat for the treatment of hyperlipidemia.
Background technology
Raising along with people's living standard, because bad dietary habit and dietary structure and life style, various " affluenza " as the sickness rate of diabetes, cardiovascular diseases, atherosclerosis, fatty liver etc., mortality rate in sustainable growth, the arch-criminal who produces above-mentioned various diseases is hyperlipidemia, therefore hyperlipidemia causes atherosclerotic independent risk factor in society's conduct now, more and more is subjected to the attention of medical circle.Atherosclerotic generation is normally increased owing to blood viscosity in the tremulous pulse, and blood flow is slow, and lipidosis too much in the blood forms atheromatous plaque and causes in blood vessel wall on the arterial blood tube wall.Brain arteriosclerosis can cause dizziness, hypomnesis even dementia, also can cause cerebral thrombosis or cerebral hemorrhage; That heart coronary artery sclerosis can cause is nervous, uncomfortable in chest, breathe hard, and severe patient can cause myocardial infarction; The obstruction of optical fundus blood capillary can cause visual impairment, even blind; The kidney blood capillary blocks can cause renal failure.Blood fat raises for a long time, and fat flushing can be piled up at liver and form fatty liver, finally causes liver cirrhosis, so prevention is very urgent with the treatment high fat of blood.In a single day the prevention hyperlipidemia also should be formed good diet and living habit, should in time treat and suffer from high fat of blood.At present the medicine of treatment high fat of blood is divided into two kinds in Chinese medicine and Western medicine substantially, sell on the present market of Chinese medicine and use " 999 capsule for descend of blood fat ", " Chinese woods QINGZHI JIAONANG " etc. are arranged, but existing Chinese medicine curative effect is not remarkable, onset is slow, treatment time is long, medicine can not reduce simultaneously to serum total cholesterol (TC), serum levels of triglyceride (TC), increasing of whole blood viscosity, and costs an arm and a leg, and the patient should not accept.Blood fat reducing aspect Western medicine (accent fat) medicine has 4～5 kinds usually, and maximum two classes that have are affirmed, used to curative effect in recent years: a class is a Statins: simvastatin (simvastatin), pravastatin and lovastatin commonly used etc.; Another kind ofly be: the special class of shellfish: fenofibrate commonly used, gemfibrozil etc.It is synthetic that Statins suppresses cholesterol, is mainly used in based on T-CHOL rising and combined hyperlipidemia familial, i.e. the disease that raises simultaneously of cholesterol and triglyceride; It is principal mode that the special class of shellfish is used for the triglyceride rising.Statins obviously reduces serum density, lipoprotein cholesterol concn, simultaneously light moderate triglyceride reducing and slight high density lipoprotein increasing cholesterol levels.But the Western medicine administration time is oversize, generally needs long-term SM that blood lipid level is controlled in the normal scope, and the chemical constituent of Western medicine has side effect to human body, takes the infringement that can cause liver, renal function and human body for a long time.
Summary of the invention
Curative effect was not significantly when the present invention had overcome above-mentioned fat-reducing medicament and adopts Chinese medicine, onset is slow, treatment time is long; Adopt Western medicine to take for a long time, the Western medicine chemical constituent easily injures the shortcoming of liver and kidney, and a kind of capsule for cleaning blood and reducing fat is provided, and this capsule is rapid-action in human body, obviously blood fat reducing in a short time, and short treating period can not impair one's health, and is the green health medicine.
The invention discloses a kind of capsule for cleaning blood and reducing fat, comprise following component: Radix Ginseng: 10～20 parts; Ganoderma: 3～5 parts; Cordyceps: 5～10 parts; Rhizoma Alismatis: 5～10 parts; 9～15 parts of Radix Et Rhizoma Rhei; Auricularia: 5～7 parts; Fructus Crataegi: 7～10 parts; Eupolyphaga Seu Steleophaga: 7～10 parts; Radix Salviae Miltiorrhizae: 10～15 parts; Radix Notoginseng: 5～10 parts; 9～15 parts of Pollen Typhaes; Sargassum: 5～7 parts; Said medicine is concocted by traditional handicraft, drying, pulverizing, effective component extracting and concentrated incapsulating form.
The pharmaceutical capsules filler preparation method be known technology, it is included in and repeatedly boils filtration in the water; Extracting solution is concentrated; Dry; Crushing screening; Incapsulate and to obtain capsule for cleaning blood and reducing fat.
The preferred group of above-mentioned each component of capsule for cleaning blood and reducing fat becomes: Radix Ginseng: 13～18 parts; Ganoderma: 4～5 parts; Cordyceps: 5～8 parts; Rhizoma Alismatis: 6～9 parts; 10～13 parts of Radix Et Rhizoma Rhei; Auricularia: 6～7 parts; Fructus Crataegi: 7～9 parts; Eupolyphaga Seu Steleophaga: 7～8 parts; Radix Salviae Miltiorrhizae: 12～154 parts; Radix Notoginseng: 7～10 parts; 9～13 parts of Pollen Typhaes; Sargassum: 5～7 parts.
Radix Ginseng, Ganoderma, Cordyceps, Moschus have that QI invigorating is had one's ideas straightened out, heat-clearing and toxic substances removing, promoting blood circulation to remove blood stasis, the deficient effect of nourishing; Radix Et Rhizoma Rhei, Rhizoma Alismatis, mountain are looked into short, bristly hair or beard, Pollen Typhae, Rhizoma Polygoni Cuspidati and are had the removing mass of purging heat, promoting flow of QI and blood, the silt expectorant effect of loosing; Radix Salviae Miltiorrhizae, Radix Notoginseng, ground beetle, Semen Persicae, Flos Carthami have activating blood circulation to dissipate blood stasis, the effect of the softening the hard mass that stimulates the menstrual flow, anti-inflammatory analgetic; Thallus Laminariae (Thallus Eckloniae), Sargassum, Fructus Ligustri Lucidi, wood and have the effect of softening the hard mass heat radiation, heat clearing away expectorant, all will share can be impelled lipid metabolism, suppress the formation of atherosclerosis and speckle, impel intestinal peristalsis promoting, increased excretions of cholesterol is drained, reduce the absorption of cholesterol, the effect of triglyceride reducing, reduction blood viscosity etc.
Common above-mentioned capsule for cleaning blood and reducing fat also comprises the component of following umber: have activating blood circulation to dissipate blood stasis, a Semen Persicae of the softening the hard mass that stimulates the menstrual flow, anti-inflammatory analgetic effect: 5～10 parts;
Or Flos Carthami: 5～10 parts;
Or have the removing mass that purges heat, promoting flow of QI and blood, the Rhizoma Polygoni Cuspidati of effect of reducing phlegm that becomes silted up looses: 10～15 parts.
Or Thallus Laminariae (Thallus Eckloniae): 5～7 parts with softening the hard mass heat radiation, heat clearing away expectorant effect.
Above-mentioned one or more components are added capsule for cleaning blood and reducing fat, after all medicines share, the better effects if of capsule for cleaning blood and reducing fat, curative effect is more obvious.
Capsule for cleaning blood and reducing fat is big at hyperlipidemia sickness rate height, hazardness among the present invention, should work out prevention, treatment combination with the characteristics of putting prevention first, and emphasis is at prevention, the ill active drug that prevents disease progression.This medicine effect is remarkable, short treating period, and general 20 days courses of treatment, general patient can recover normal index a course of treatment.Capsule for cleaning blood and reducing fat of the present invention adopts pure Chinese medicinal preparation, therefore can not damage health, is the green health medicine.
The specific embodiment
The specific embodiment 1:
A kind of capsule for cleaning blood and reducing fat comprises following component: Radix Ginseng: 10 grams; Ganoderma: 5 grams; Cordyceps: 9 grams; Rhizoma Alismatis: 9.5 grams; Radix Et Rhizoma Rhei 10 grams; Auricularia: 5～7 grams; Fructus Crataegi: 7～10 grams; Eupolyphaga Seu Steleophaga: 7～10 grams; Radix Salviae Miltiorrhizae: 15 grams; Radix Notoginseng: 6 grams; Pollen Typhae 14 grams; Sargassum: 5 grams; Said medicine is concocted by traditional handicraft, drying, pulverizing, effective component extracting and concentrated incapsulating form.
The specific embodiment 2:
A kind of capsule for cleaning blood and reducing fat comprises following component: Radix Ginseng: 16 grams; Ganoderma: 4 grams; Cordyceps: 8 grams; Rhizoma Alismatis: 7 grams; Radix Et Rhizoma Rhei 12 grams; Auricularia: 6 grams; Fructus Crataegi: 8 grams; Eupolyphaga Seu Steleophaga: 7.5 grams; Radix Salviae Miltiorrhizae: 13 grams; Radix Notoginseng: 7 grams; Pollen Typhae 13 grams; Sargassum: 6 grams; Said medicine is concocted by traditional handicraft, drying, pulverizing, effective component extracting and concentrated incapsulating form.
The specific embodiment 3:
A kind of capsule for cleaning blood and reducing fat comprises following component: Radix Ginseng: 10 grams; Ganoderma: 3 grams; Cordyceps: 6 grams; Rhizoma Alismatis: 6 grams; Radix Et Rhizoma Rhei 9.5 grams; Auricularia: 6 grams; Fructus Crataegi: 8 grams; Eupolyphaga Seu Steleophaga: 7.5 grams; Radix Salviae Miltiorrhizae: 11 grams; Radix Notoginseng: 6 grams; Pollen Typhae 10 grams; Sargassum: 6 grams; Semen Persicae: 6 grams; Rhizoma Polygoni Cuspidati: 12 grams, said medicine is concocted by traditional handicraft, drying, pulverizing, effective component extracting and concentrated incapsulating form.
The specific embodiment 4:
A kind of capsule for cleaning blood and reducing fat comprises following component: Radix Ginseng: 19 grams; Ganoderma: 4 grams; Cordyceps: 9 grams; Rhizoma Alismatis: 9 grams; Radix Et Rhizoma Rhei 10 grams; Auricularia: 5 grams; Fructus Crataegi: 10 grams; Eupolyphaga Seu Steleophaga: 6 grams; Radix Salviae Miltiorrhizae: 10 grams; Radix Notoginseng: 10 grams; Pollen Typhae 14 grams; Sargassum: 6 grams; Thallus Laminariae (Thallus Eckloniae) 7 grams are concocted said medicine by traditional handicraft, drying, pulverizing, and effective component extracting and concentrated incapsulating form.
The specific embodiment 5:
A kind of capsule for cleaning blood and reducing fat comprises following component: Radix Ginseng: 10 grams; Ganoderma: 5 grams; Cordyceps: 10 grams; Rhizoma Alismatis: 8 grams; Radix Et Rhizoma Rhei 12 grams; Auricularia: 6 grams; Fructus Crataegi: 8 grams; Eupolyphaga Seu Steleophaga: 8 grams; Radix Salviae Miltiorrhizae: 13 grams; Radix Notoginseng: 10 grams; Pollen Typhae 15 grams; Sargassum: 7 grams; Flos Carthami: 10 grams, said medicine is concocted by traditional handicraft, drying, pulverizing, effective component extracting and concentrated incapsulating form.
The specific embodiment 6:
A kind of capsule for cleaning blood and reducing fat comprises following component: Radix Ginseng: 10 grams; Ganoderma: 3 grams; Cordyceps: 6 grams; Rhizoma Alismatis: 6 grams; Radix Et Rhizoma Rhei 9.5 grams; Auricularia: 6 grams; Fructus Crataegi: 8 grams; Eupolyphaga Seu Steleophaga: 7.5 grams; Radix Salviae Miltiorrhizae: 11 grams; Radix Notoginseng: 6 grams; Pollen Typhae 10 grams; Sargassum: 6 grams; Semen Persicae: 6 grams; Rhizoma Polygoni Cuspidati: 12 grams; Thallus Laminariae (Thallus Eckloniae) 7 grams; Flos Carthami: 10 grams, said medicine is concocted by traditional handicraft, drying, pulverizing, effective component extracting and concentrated incapsulating form.
Claims (6)
1, a kind of capsule for cleaning blood and reducing fat comprises following component: Radix Ginseng: 10～20 parts; Ganoderma: 3～5 parts; Cordyceps: 5～10 parts; Rhizoma Alismatis: 5～10 parts; 9～15 parts of Radix Et Rhizoma Rhei; Auricularia: 5～7 parts; Fructus Crataegi: 7～10 parts; Eupolyphaga Seu Steleophaga: 7～10 parts; Radix Salviae Miltiorrhizae: 10～15 parts; Radix Notoginseng: 5～10 parts; 9～15 parts of Pollen Typhaes; Sargassum: 5～7 parts; Said medicine is concocted by traditional handicraft, drying, pulverizing, effective component extracting and concentrated incapsulating form.
2, capsule for cleaning blood and reducing fat according to claim 1 is characterized in that: the preferred umber of described each component is: Radix Ginseng: 13～18 parts; Ganoderma: 4～5 parts; Cordyceps: 5～8 parts; Rhizoma Alismatis: 6～9 parts; 10～13 parts of Radix Et Rhizoma Rhei; Auricularia: 6～7 parts; Fructus Crataegi: 7～9 parts; Eupolyphaga Seu Steleophaga: 7～8 parts; Radix Salviae Miltiorrhizae: 12～154 parts; Radix Notoginseng: 7～10 parts; 9～13 parts of Pollen Typhaes; Sargassum: 5～7 parts.
3, capsule for cleaning blood and reducing fat according to claim 1 is characterized in that: described component also comprises: Semen Persicae: 5～10 parts.
4, capsule for cleaning blood and reducing fat according to claim 1 is characterized in that: described component also comprises: Rhizoma Polygoni Cuspidati: 10～15 parts.
5, capsule for cleaning blood and reducing fat according to claim 1 is characterized in that: described component also comprises: 5～7 parts of Thallus Laminariae (Thallus Eckloniae)s.
6, capsule for cleaning blood and reducing fat according to claim 1 is characterized in that: described component also comprises: Flos Carthami: 5～10 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021354197A CN1150942C (en) | 2002-08-13 | 2002-08-13 | Capsule for cleaning blood and reducing fat |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021354197A CN1150942C (en) | 2002-08-13 | 2002-08-13 | Capsule for cleaning blood and reducing fat |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1400016A true CN1400016A (en) | 2003-03-05 |
| CN1150942C CN1150942C (en) | 2004-05-26 |
Family
ID=4748192
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB021354197A Expired - Fee Related CN1150942C (en) | 2002-08-13 | 2002-08-13 | Capsule for cleaning blood and reducing fat |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1150942C (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1330345C (en) * | 2005-05-17 | 2007-08-08 | 广西梧州制药（集团）股份有限公司 | Combination of Chinese traditional medicine for treating hyperlipemia, and preparation method |
| CN103566047A (en) * | 2013-12-02 | 2014-02-12 | 杭州国草生物科技有限公司 | Cordyceps sinensis composition capable of reducing blood fat |
| CN104189408A (en) * | 2014-09-28 | 2014-12-10 | 李长娟 | Chinese herbal preparation for effectively treating hyperlipidemia |
| CN105435130A (en) * | 2016-01-12 | 2016-03-30 | 福建中医药大学附属康复医院 | External traditional Chinese medicine formula for treating phlegm-stasis collateral blocking type turbid blood disease |
-
2002
- 2002-08-13 CN CNB021354197A patent/CN1150942C/en not_active Expired - Fee Related
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1330345C (en) * | 2005-05-17 | 2007-08-08 | 广西梧州制药（集团）股份有限公司 | Combination of Chinese traditional medicine for treating hyperlipemia, and preparation method |
| CN103566047A (en) * | 2013-12-02 | 2014-02-12 | 杭州国草生物科技有限公司 | Cordyceps sinensis composition capable of reducing blood fat |
| CN103566047B (en) * | 2013-12-02 | 2016-09-21 | 杭州国草生物科技有限公司 | A kind of cordyceps sinensis composition of blood fat reducing |
| CN104189408A (en) * | 2014-09-28 | 2014-12-10 | 李长娟 | Chinese herbal preparation for effectively treating hyperlipidemia |
| CN105435130A (en) * | 2016-01-12 | 2016-03-30 | 福建中医药大学附属康复医院 | External traditional Chinese medicine formula for treating phlegm-stasis collateral blocking type turbid blood disease |
| CN105435130B (en) * | 2016-01-12 | 2019-10-08 | 福建中医药大学附属康复医院 | A kind of external application Chinese medicine prescription for treating the turbid disease of phlegm-stasis blocking collateral type blood |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1150942C (en) | 2004-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101690764B (en) | Traditional Chinese medicine for treating cardiac, cerebral and vascular diseases and preparation method thereof | |
| CN1224614A (en) | Medicine for preventing and curing cardiac and cerebral vascular diseases and its preparation | |
| CN1150942C (en) | Capsule for cleaning blood and reducing fat | |
| CN110327427A (en) | It is a kind of to treat morning, the Chinese medicine composition of mid-term high blood pressure and preparation method | |
| CN101085233A (en) | Civil Chinese medicinal herb with hypotensive, antilipemic and hypoylycemic function | |
| CN1283497A (en) | Oral liquid for treating cerebrovascular disease and its preparing process | |
| CN1101199C (en) | Chinese-medicinal capsule for treating hyperlipomia | |
| CN1245197C (en) | Chinese medicine preparation for treating coronary heart disease and viral myocarditis | |
| CN1244367C (en) | 'Dianjian' liqid for curing epilepsy sickness | |
| CN1255149C (en) | Combination of medication | |
| CN103735879A (en) | Traditional Chinese medicine decoction for treating carotid artery plaque | |
| CN103784626A (en) | Medicine for treating arteriosclerotic diseases by traditional Chinese medicines and preparation method of medicine | |
| CN1322558A (en) | an anti-cancer drug | |
| CN1319562C (en) | Disinfectant bactericidal Chinese medicine preparation and producing process thereof | |
| CN1857607A (en) | Chinese medicine preparation for treating cardiac and cerebral vascular diseases and its preparing process | |
| CN1228308A (en) | Preparation capable of reducing cholesterol and protecting heart | |
| CN1762440A (en) | Medicine for preventing and treating cardiovascular and cerebrovascular diseases | |
| CN101301384A (en) | Chinese medicinal composition for treating arteriosclerosis | |
| CN120267783A (en) | A Chinese medicinal composition for treating apoplexy, vascular thrombosis, arteriosclerosis, coronary heart disease or lumbago and skelalgia | |
| CN1265829C (en) | Healthy product for preventing and treating cardiovascular and cerebrovascular disease | |
| CN1075091A (en) | The preparation method of NAOXUESHUAN PIAN | |
| CN1352979A (en) | Chinese medicine for replenishing vital energy and promoting blood circulation | |
| CN110694014A (en) | A composition for preventing and treating thrombosis | |
| CN1965924A (en) | Medicament for lowering blood fat and dilating coronary artery | |
| CN105343358A (en) | Traditional Chinese medicine capsules for treating coronary heart disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |